Departments of Neurosurgery are Leaders in Highly Cited Glioblastoma Research
Departments of neurosurgery have established themselves as key drivers in GBM research. The prominence of tumor biology and immunotherapy reflect broader shifts in treatment approaches. Continued support for neurosurgical departments and targeted funding initiatives is essential for advancing GBM research, fostering innovation, and improving patient outcomes in this challenging field.
Authors
- Bob S. Carter (ORCID: https://orcid.org/0000-0002-3586-1324)
- Masih Tazhibi
- Samuel J. Steuart (ORCID: https://orcid.org/0009-0009-5786-4380)
- Parker Kotlarz (ORCID: https://orcid.org/0000-0003-3667-8908)
- E. Antonio Chiocca (ORCID: https://orcid.org/0000-0001-5183-1670)
- Bryan D. Choi (ORCID: https://orcid.org/0000-0002-5090-2470)
- William T. Curry (ORCID: https://orcid.org/0000-0002-8036-1847)
- Rishab Ramapriyan (ORCID: https://orcid.org/0000-0002-2945-3236)
- Adrian Kalaw (ORCID: https://orcid.org/0000-0002-8125-1957)
- Brian V. Nahed (ORCID: https://orcid.org/0000-0001-8537-106X)
- Mona Tazhibi
Institutions
- Harvard University (US)
- Massachusetts General Hospital (US)
- Neurological Surgery (US)
- University of Pennsylvania (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- Neurosurgery Open
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1227/neuprac.0000000000000170
- Primary Topic
- Health and Medical Research Impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00